Tegaserod Treatment for IBS: A Model of Indirect Costs
Economic Impact of Irritable Bowel Syndrome: What Does the Future Hold?
Effectiveness of Tegaserod Therapy on GI-related Resource Utilization in a Managed Care Population
Total Costs of IBS: Employer and Managed Care Perspective
Budget Impact of Tegaserod on a Managed Care Organization Formulary
Impairment in Work Productivity and Health-related Quality of Life in Patients With IBS
2 Clarke Drive Cranbury, NJ 08512